. ,

Domenico Ribatti1, Roberto Tamma1, Giuseppe Ingravallo2

  • 1Department of Translational Biomedicine and Neuroscience, University of Bari Medical School, Bari, Italy.

Frontiers in oncology
|October 24, 2025
PubMed
概括

向瘤血管生成是血液恶性瘤的关键进展. 对淋巴瘤而言,抗血管原体单一治疗往往是不成功的,因此需要结合策略来改善结果.